Stock Groups

Evonik Q3 core profit broadly in-line on increased demand, higher pricing -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: This is the logo of Evonik Industries AG, a German specialty chemical manufacturer, at their Bitterfeld, Germany plant on February 29 2016. REUTERS/Fabrizio Bensch

(Reuters) – German chemicals company Evonik Industries has reported an increase in demand and higher pricing for the third quarter. The adjusted core profit was roughly on par with analysts’ estimates.

This company makes products that include animal feed, diapers, and ingredients for Pfizer/BioNTech’s COVID-19 vaccine. It reported adjusted earnings before interest taxes, depreciation, and amortization (EBITDA), of 645 millions euros for the third quarter. That’s 24% more than analysts expected and slightly higher than their forecast of 641.1million euros, according to a poll.

($1 = 0.8632 euros)

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses caused by the data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]